NCT06915727 - An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions

Childhood Malignant Solid NeoplasmChildhood Malignant Thoracic NeoplasmMalignant Abdominal NeoplasmMalignant Neck NeoplasmMalignant Pelvic NeoplasmMetastatic Childhood Malignant Solid Neoplasm

Interventions

PROCEDURE

Biospecimen Collection

Undergo tissue sample collection

PROCEDURE

Near Infrared Imaging

Undergo NIR fluorescent imaging

DRUG

Pafolacianine Sodium

Given IV

PROCEDURE

Surgical Procedure

Undergo SOC surgery

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester